Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.29 - $4.04 $107,960 - $338,107
-83,690 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.45 - $6.05 $4,240 - $7,435
-1,229 Reduced 1.45%
83,690 $322,000
Q3 2021

Nov 15, 2021

BUY
$5.53 - $9.28 $50,251 - $84,327
9,087 Added 11.98%
84,919 $474,000
Q2 2021

Aug 16, 2021

BUY
$7.84 - $12.6 $33,813 - $54,343
4,313 Added 6.03%
75,832 $674,000
Q1 2021

May 17, 2021

SELL
$10.54 - $19.3 $257,365 - $471,267
-24,418 Reduced 25.45%
71,519 $908,000
Q4 2020

Feb 12, 2021

BUY
$12.79 - $17.1 $67,876 - $90,749
5,307 Added 5.86%
95,937 $1.34 Million
Q3 2020

Nov 16, 2020

SELL
$12.99 - $19.41 $144,539 - $215,975
-11,127 Reduced 10.93%
90,630 $1.18 Million
Q2 2020

Aug 14, 2020

SELL
$12.19 - $22.96 $222,309 - $418,721
-18,237 Reduced 15.2%
101,757 $1.78 Million
Q1 2020

May 15, 2020

BUY
$10.08 - $27.21 $174,877 - $472,066
17,349 Added 16.9%
119,994 $1.87 Million
Q4 2019

Feb 14, 2020

BUY
$13.05 - $21.88 $54,144 - $90,780
4,149 Added 4.21%
102,645 $2.07 Million
Q3 2019

Nov 14, 2019

BUY
$14.12 - $23.44 $292,396 - $485,395
20,708 Added 26.62%
98,496 $1.39 Million
Q2 2019

Aug 14, 2019

SELL
$13.21 - $27.29 $16,486 - $34,057
-1,248 Reduced 1.58%
77,788 $1.27 Million
Q1 2019

May 15, 2019

BUY
$12.46 - $22.05 $622,165 - $1.1 Million
49,933 Added 171.57%
79,036 $1.74 Million
Q4 2018

Feb 14, 2019

BUY
$15.43 - $32.7 $449,059 - $951,668
29,103 New
29,103 $485,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.